Galecto Inc (GLTO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : GLTO Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2025-01-07 2025-01-03 V Vente

Firmani Lori

Interim CFO

Dirigeant
261 -36.0%
5,63
1 469 USD 		261 -36.0% 5,63 1 469 USD
2025-01-07 2025-01-03 V Vente

Schambye Hans T.

Chief Executive Officer

Administrateur exécutif
1 341 -28.3%
5,60
7 510 USD 		1 341 -28.3% 5,60 7 510 USD
2025-01-07 2025-01-03 V Vente

Winslow Garrett

General Counsel

Dirigeant
471 -31.8%
5,60
2 638 USD 		471 -31.8% 5,60 2 638 USD
2023-08-17 2023-08-15 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
535 534 -26.2%
0,75
401 651 USD 		535 534 -26.2% 0,75 401 651 USD
2023-08-17 2023-08-15 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
248 819 -28.3%
0,75
186 614 USD 		248 819 -28.3% 0,75 186 614 USD
2023-08-17 2023-08-15 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
38 327 -28.3%
0,75
28 745 USD 		38 327 -28.3% 0,75 28 745 USD
2023-08-02 2023-07-31 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
153 078 -6.8%
3,00
459 234 USD 		153 078 -6.8% 3,00 459 234 USD
2023-08-02 2023-07-31 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
29 700 -3.3%
3,00
89 100 USD 		29 700 -3.3% 3,00 89 100 USD
2023-08-02 2023-07-31 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
26 622 -16.4%
3,00
79 866 USD 		26 622 -16.4% 3,00 79 866 USD
2023-07-27 2023-07-25 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
26 700 -1.2%
2,92
77 964 USD 		26 700 -1.2% 2,92 77 964 USD
2023-07-27 2023-07-25 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
4 700 -0.5%
2,92
13 724 USD 		4 700 -0.5% 2,92 13 724 USD
2023-07-27 2023-07-25 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
7 800 -4.6%
2,92
22 776 USD 		7 800 -4.6% 2,92 22 776 USD
2023-07-17 2023-07-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
132 100 -5.5%
2,40
317 040 USD 		132 100 -5.5% 2,40 317 040 USD
2023-07-17 2023-07-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
52 800 -5.5%
2,40
126 720 USD 		52 800 -5.5% 2,40 126 720 USD
2023-07-17 2023-07-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
9 800 -5.5%
2,40
23 520 USD 		9 800 -5.5% 2,40 23 520 USD
2023-04-17 2023-04-17 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
8 878 -0.4%
1,97
17 490 USD 		8 878 -0.4% 1,97 17 490 USD
2023-04-17 2023-04-17 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
3 551 -0.4%
1,97
6 995 USD 		3 551 -0.4% 1,97 6 995 USD
2023-04-17 2023-04-17 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
660 -0.4%
1,97
1 300 USD 		660 -0.4% 1,97 1 300 USD
2023-04-17 2023-04-14 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
28 110 -1.1%
1,86
52 285 USD 		28 110 -1.1% 1,86 52 285 USD
2023-04-17 2023-04-14 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
11 245 -1.1%
1,86
20 916 USD 		11 245 -1.1% 1,86 20 916 USD
2023-04-17 2023-04-14 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
2 091 -1.1%
1,86
3 889 USD 		2 091 -1.1% 1,86 3 889 USD
2023-04-17 2023-04-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
9 459 -0.4%
1,82
17 215 USD 		9 459 -0.4% 1,82 17 215 USD
2023-04-17 2023-04-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
3 784 -0.4%
1,82
6 887 USD 		3 784 -0.4% 1,82 6 887 USD
2023-04-17 2023-04-13 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
703 -0.4%
1,82
1 279 USD 		703 -0.4% 1,82 1 279 USD
2023-04-12 2023-04-12 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
1 603 -0.1%
1,81
2 901 USD 		1 603 -0.1% 1,81 2 901 USD
2023-04-12 2023-04-12 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
641 -0.1%
1,81
1 160 USD 		641 -0.1% 1,81 1 160 USD
2023-04-12 2023-04-12 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
119 -0.1%
1,81
215 USD 		119 -0.1% 1,81 215 USD
2023-04-12 2023-04-11 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
9 459 -0.4%
1,82
17 215 USD 		9 459 -0.4% 1,82 17 215 USD
2023-04-12 2023-04-11 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
3 784 -0.4%
1,82
6 887 USD 		3 784 -0.4% 1,82 6 887 USD
2023-04-12 2023-04-11 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
703 -0.4%
1,82
1 279 USD 		703 -0.4% 1,82 1 279 USD
2023-04-12 2023-04-10 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
34 745 -1.4%
1,79
62 194 USD 		34 745 -1.4% 1,79 62 194 USD
2023-04-12 2023-04-10 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
13 899 -1.4%
1,79
24 879 USD 		13 899 -1.4% 1,79 24 879 USD
2023-04-12 2023-04-10 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
2 584 -1.4%
1,79
4 625 USD 		2 584 -1.4% 1,79 4 625 USD
2023-04-07 2023-04-06 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
6 558 -0.3%
2,00
13 116 USD 		6 558 -0.3% 2,00 13 116 USD
2023-04-07 2023-04-06 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
2 620 -0.3%
2,00
5 240 USD 		2 620 -0.3% 2,00 5 240 USD
2023-04-07 2023-04-06 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
487 -0.3%
2,00
974 USD 		487 -0.3% 2,00 974 USD
2023-04-07 2023-04-05 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
63 058 -2.4%
2,18
137 466 USD 		63 058 -2.4% 2,18 137 466 USD
2023-04-07 2023-04-05 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
25 220 -2.4%
2,18
54 980 USD 		25 220 -2.4% 2,18 54 980 USD
2023-04-07 2023-04-05 V Vente

ORBIMED ADVISORS LLC

Actionnaire important
4 687 -2.4%
2,18
10 218 USD 		4 687 -2.4% 2,18 10 218 USD
2022-03-23 2022-03-22 A Achat

Schambye Hans T.

Chief Executive Officer

Administrateur exécutif
5 000 +10.5%
2,15
10 750 USD 		5 000 +10.5% 2,15 10 750 USD
2022-03-23 2022-03-22 A Achat

Lindmark Bertil

Chief Medical Officer

Dirigeant
14 604 +730.2%
2,16
31 545 USD 		14 604 +730.2% 2,16 31 545 USD
2021-12-06 2021-12-03 A Achat

Freve Jonathan

Chief Financial Officer

Dirigeant
4 000 +50.0%
2,49
9 960 USD 		4 000 +50.0% 2,49 9 960 USD
2021-12-06 2021-12-03 A Achat

Winslow Garrett

General Counsel

Dirigeant
2 000 +100.0%
2,48
4 960 USD 		2 000 +100.0% 2,48 4 960 USD
2021-11-10 2021-11-09 A Achat

Schambye Hans T.

Chief Executive Officer

Administrateur exécutif
4 500 +10.5%
3,50
15 750 USD 		4 500 +10.5% 3,50 15 750 USD
2021-11-09 2021-11-08 A Achat

Freve Jonathan

Chief Financial Officer

Dirigeant
3 000 +60.0%
3,40
10 200 USD 		3 000 +60.0% 3,40 10 200 USD
2021-06-28 2021-06-28 A Achat

Lindmark Bertil

Chief Medical Officer

Dirigeant
2 000 +inf%
5,26
10 520 USD 		2 000 +inf% 5,26 10 520 USD
2021-06-24 2021-06-24 A Achat

Schambye Hans T.

Chief Executive Officer

Administrateur exécutif
3 000 +7.5%
5,11
15 330 USD 		3 000 +7.5% 5,11 15 330 USD
2020-11-04 2020-11-02 A Achat

Novo Holdings A/S

Actionnaire important
333 333 +15.4%
15,00
4 999 995 USD 		333 333 +15.4% 15,00 4 999 995 USD
2020-11-04 2020-11-02 A Achat

Khuong Chau Quang

Administrateur non-exécutif Actionnaire important
209 500 +25.5%
15,00
3 142 500 USD 		209 500 +25.5% 15,00 3 142 500 USD
2020-11-04 2020-11-02 A Achat

Khuong Chau Quang

Administrateur non-exécutif Actionnaire important
523 833 +25.5%
15,00
7 857 495 USD 		523 833 +25.5% 15,00 7 857 495 USD
2020-11-04 2020-11-02 A Achat

Christgau Stephan

Administrateur non-exécutif
66 666 +13.9%
15,00
999 990 USD 		66 666 +13.9% 15,00 999 990 USD
2020-11-04 2020-11-02 A Achat

ORBIMED ADVISORS LLC

Administrateur non-exécutif Actionnaire important
209 500 +25.5%
15,00
3 142 500 USD 		209 500 +25.5% 15,00 3 142 500 USD
2020-11-04 2020-11-02 A Achat

ORBIMED ADVISORS LLC

Administrateur non-exécutif Actionnaire important
523 833 +25.5%
15,00
7 857 495 USD 		523 833 +25.5% 15,00 7 857 495 USD
// ... existing code ... // ... rest of the file ...